Allopurinol NEW
| Price | $65 |
| Package | 10g |
| Supply Ability: | 10g |
| Update Time: | 2026-07-13 |
Product Details
| Product Name: Allopurinol | CAS No.: 315-30-0 |
| Purity: 99.36% | Supply Ability: 10g |
| Release date: 2026/07/13 |
Product Introduction
Bioactivity
| Name | Allopurinol |
| Description | Allopurinol (Zyloric) is a Xanthine Oxidase Inhibitor. The mechanism of action of allopurinol is as a Xanthine Oxidase Inhibitor. |
| In vitro | 10 mM Allopurinol inhibited the activity of oxygen xanthine oxidase produced by hypoxia-reoxygenation injury.Allopurinol reduced intracellular Ca2+ concentration by enhancing xanthine oxidase activity.Allopurinol reversed the increase in xanthine oxidase activity in neonatal rat hearts with ischemia-reperfusion injury. |
| In vivo | 10 mM Allopurinol inhibited the activity of oxygen xanthine oxidase produced by hypoxia-reoxygenation injury.Allopurinol reduced intracellular Ca2+ concentration by enhancing xanthine oxidase activity.Allopurinol reversed the increase in xanthine oxidase activity in neonatal rat hearts with ischemia-reperfusion injury. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | Ethanol : 3 mg/mL (22.04 mM), Sonication is recommended. H2O : Insoluble 10% DMSO+40% PEG300+5% Tween-80+45% Saline : 0.5 mg/mL (3.67 mM), Sonication is recommended. DMSO : 16.4 mg/mL (120.49 mM), Sonication is recommended. |
| Keywords | XO | XanthineOxidase | Xanthine Oxidase | orally active | Inhibitor | inhibit | hyperuricemia | HUVEC cells | HIF-2α | HIF-1α | gout | anti-nociception | anti-leishmanial | anti-depressant | Allopurinol |
| Inhibitors Related | Ethoxyquin | Kaolin | Imeglimin hydrochloride | L-Ascorbic acid | Ethyl linoleate | Magnesium acetate tetrahydrate | Inosine | L-Cystine | Dimethyl itaconate | Copper Sulfate Pentahydrate | L-Ascorbic acid sodium salt | Dimethyl phthalate |
| Related Compound Libraries | Bioactive Compound Library | EMA Approved Drug Library | Anti-Cancer Clinical Compound Library | Anti-Viral Compound Library | Drug Repurposing Compound Library | Inhibitor Library | FDA-Approved Drug Library | Anti-Cancer Approved Drug Library | Immunology/Inflammation Compound Library | Anti-Aging Compound Library | Bioactive Compounds Library Max | Anti-Cancer Drug Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
|
VIP6Y
|
Sinoway Industrial co., ltd.
|
2026-07-20 | ||
|
VIP6Y
|
WUHAN FORTUNA CHEMICAL CO., LTD
|
2026-07-20 | ||
| $100.00 |
VIP2Y
|
HEBEI SHENGSUAN CHEMICAL INDUSTRY CO.,LTD
|
2026-07-16 | |
| $65.00 |
VIP4Y
|
TargetMol Chemicals Inc.
|
2026-07-14 | |
| $65.00 |
VIP2Y
|
TargetMol Chemicals Inc.
|
2026-07-14 | |
|
VIP2Y
|
Shaanxi Dideu New Materials Co. Ltd
|
2026-07-13 | ||
| $10.00 |
Hebei Chuanghai Biotechnology Co., Ltd
|
2026-03-20 | ||
| $12.00 |
Hebei Yanxi Chemical Co., Ltd.
|
2025-06-20 | ||
|
VIP3Y
|
Shaanxi TNJONE Pharmaceutical Co., Ltd
|
2025-04-02 | ||
| $100.00 |
Hebei Fengqiang Trading Co., LTD
|
2023-08-31 |
United States- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, MA
INQUIRY